Price Alert

Maison Solutions Inc. Cla... (MSS)

NASDAQ: MSS · Real-Time Price · USD

0.97

-0.09 (-8.49%)

At close: Oct 03, 2025, 3:59 PM

0.98

1.09%

Pre-market: Oct 06, 2025, 05:20 AM EDT

-8.49% (1D)

Bid	0.97
Market Cap	16.92M
Revenue (ttm)	121.73M
Net Income (ttm)	-1.07M
EPS (ttm)	-0.02
PE Ratio (ttm)	-48.47
Forward PE	n/a
Analyst	Strong Buy
Dividends	n/a

Ask	1.03
Volume	1,165,828
Avg. Volume (20D)	2,199,093
Open	1.04
Previous Close	1.06
Day's Range	0.96 - 1.08
52-Week Range	0.80 - 3.96
Beta	4.97
Ex-Dividend Date	n/a

About MSS

undefined

[Read more]

Industry n/a

Sector n/a

IPO Date n/a

Employees NaN

Stock Exchange n/a

Ticker Symbol MSS

Website n/a

Full Company Profile

Analyst Forecast

According to 0 analyst ratings, the average rating for MSS stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

Stock Forecasts

Why Price Moved

1 week ago

+17.28%

Maison Solutions shares are trading higher after t... Unlock content with Pro Subscription

9 months ago

+13.73%

Maison Solutions shares are trading higher after the company reported a year-over-year increase in Q2 revenue results.

News

1 week ago · accessnewswire.com

Maison Solutions Secures up to $70 Million Private Placement to Launch Worldcoin (WLD) Digital Asset Treasury

MONTEREY PARK, CALIFORNIA / ACCESS Newswire / September 29, 2025 / Maison Solutions Inc. (NASDAQ:MSS) ("Maison Solutions" or the "Company"), a U.S.-based specialty grocery retailer offering traditiona...

2 weeks ago · accessnewswire.com

Maison Solutions Reports First Quarter 2026 Financial Results

MONTEREY PARK, CA / ACCESS Newswire / September 22, 2025 / Maison Solutions Inc. (NASDAQ:MSS) ("Maison Solutions" or the "Company"), a U.S.-based specialty grocery retailer offering traditional Asian ...

3 weeks ago · accessnewswire.com

Maison Solutions Signs Distribution Agreement with Guizhou Moutai Chiew Import and Export

Distribution Agreement Covers China's Premium Luxury Liquor, 53° Flying Fair Moutai Chiew MONTEREY PARK, CA / ACCESS Newswire / September 11, 2025 / Maison Solutions Inc. (NASDAQ:MSS) ("Maison Solutio...

3 weeks ago · seekingalpha.com

Syndax Pharmaceuticals: Revumenib PDUFA Review mNPM1 AML And Move Towards MSS CRC

FDA approval of revumenib for r/r KMT2Ar AML patients drives strong revenue growth for Syndax Pharmaceuticals, with Q2 2025 sales up 43% quarter-over-quarter. Upcoming FDA Priority Review decision for...

1 month ago · accessnewswire.com

Maison Solutions Reports Fiscal Year 2025 Financial Results

MONTEREY PARK, CALIFORNIA / ACCESS Newswire / August 14, 2025 / Maison Solutions Inc. (NASDAQ:MSS) ("Maison Solutions" or the "Company"), a U.S.-based specialty grocery retailer offering traditional A...